期刊文献+

两个遗传性纤维蛋白原缺陷症家系表型与基因突变分析 被引量:1

Phenotype and genotype analyses of two pedigrees with inherited fibrinogen deficiency
原文传递
导出
摘要 目的对两个杂合突变导致遗传性纤维蛋白原缺陷症家系进行表型和基因突变分析,并初步探讨其分子致病机制。方法采用凝固法检测两个先证者及其各自家系成员(3代9人和2代3人)凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)和纤维蛋白原活性(Fg∶C),免疫比浊法检测纤维蛋白原抗原(Fg∶Ag)。DNA直接测序法分析先证者FGA、FGB和FGG基因所有外显子和侧翼序列及家系成员相应的突变位点区域。通过凝血酶诱导进行纤维蛋白原聚集试验;用ClustalX-2、1-win软件分析突变位点的保守性;用Mutation Taster、PolyPhen-2、PROVEAN、SIFT和LRT在线生物信息学软件预测突变位点的致病性;用Swiss-pdb Viewer4.0.1分析突变前后蛋白质空间结构及分子作用力的变化。结果家系1先证者和家系2先证者Fg∶C明显下降(分别为1.28 g/L、0.98 g/L);家系1先证者Fg∶Ag正常(2.20 g/L),家系2先证者Fg∶Ag降低(1.01 g/L)。基因分析发现,家系1先证者的FGB基因第2号外显子存在c.293C>A(p.BβAla98Asp)杂合错义突变;家系2先证者的FGB基因第8号外显子存在c.1418C>G(p.BβSer473*)杂合无义突变。同源性分析表明Ala98和Ser473残基在同源物种间呈不同保守状态;在线生物信息学软件预测显示p.BβAla98Asp和p.BβSer473*突变为致病突变;蛋白模型分析显示,p.BβAla98Asp突变使氨基酸之间的氢键发生改变,p.BβSer473*突变产生了截短蛋白。结论家系1先证者的异常纤维蛋白原血症和家系2先证者的低纤维蛋白原血症可能分别与p.BβAla98Asp杂合错义突变及p.BβSer473*杂合无义突变有关。 Objective To analyze the phenotype and genotype of two pedigrees with inherited fibrinogen(Fg)deficiency caused by two heterozygous mutations.We also preliminarily probed the molecular pathogenesis.Methods The prothrombin time(PT),activated partial thromboplastin time(APTT),thrombin time(TT)and plasma fibrinogen activity(Fg∶C)of all family members(nine people across three generations and three people across two generations)were measured by the clotting method.Fibrinogen antigen(Fg:Ag)was measured by immunoturbidimetry.Direct DNA sequencing was performed to analyze all exons,flanking sequences,and mutated sites of FGA,FGB,and FGG for all members.Thrombin-catalyzed fibrinogen polymerization was performed.ClustalX 2.1 software was used to analyze the conservatism of the mutated sites.MutationTaster,PolyPhen-2,PROVEAN,SIFT,and LRT online bioinformatics software were applied to predict pathogenicity.Swiss PDB Viewer 4.0.1 was used to analyze the changes in protein spatial structure and molecular forces before and after mutation.Results The Fg∶C of two probands decreased(1.28 g/L and 0.98 g/L,respectively).The Fg∶Ag of proband 1 was in the normal range of 2.20 g/L,while it was decreased to 1.01 g/L in proband 2.Through genetic analysis,we identified a heterozygous missense mutation(c.293C>A;p.BβAla98Asp)in exon 2 of proband 1 and a heterozygous nonsense mutation(c.1418C>G;p.BβSer473*)in exon 8 of proband 2.The conservatism analysis revealed that Ala98 and Ser473 presented different conservative states among homologous species.Online bioinformatics software predicted that p.BβAla98Asp and p.BβSer473*were pathogenic.Protein models demonstrated that the p.BβAla98Asp mutation influenced hydrogen bonds between amino acids,and the p.BβSer473*mutation resulted in protein truncation.Conclusion The dysfibrinogenemia of proband 1 and the hypofibrinogenemia of proband 2 appeared to be related to the p.BβAla98Asp heterozygous missense mutation and the p.BβSer473*heterozygous nonsense mutation,respectively.This is the first ever report of these mutations.
作者 贾恺琦 苏正仙 陈荟琳 郑晓勇 曾蔓霖 张柯 叶龙颖 杨丽红 金艳慧 王明山 Jia Kaiqi;Su Zhengxian;Chen Huilin;Zheng Xiaoyong;Zeng Manlin;Zhang Ke;Ye Longying;Yang Lihong;Jin Yanhui;Wang Mingshan(Department of Clinical Laboratory,Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325015,China)
出处 《中华血液学杂志》 CAS CSCD 北大核心 2023年第11期930-935,共6页 Chinese Journal of Hematology
基金 温州市科技计划基金(Y20220746) 浙江省检验诊断及转化研究重点实验室项目(2022E10022)。
关键词 纤维蛋白原缺陷症 基因突变 纤维蛋白原 蛋白模型 Fibrinogen deficiency Gene mutation Fibrinogen Protein model
  • 相关文献

参考文献5

二级参考文献23

  • 1方怡,王学锋,傅启华,武文漫,丁秋兰,戴菁,周荣富,王文斌,谢爽,王鸿利.一个纤维蛋白原γ链Arg275His突变导致的遗传性异常纤维蛋白原血症家系[J].中华医学遗传学杂志,2005,22(2):201-203. 被引量:27
  • 2Matsuda M, Sugo T. Hereditary disorders of fibrinogen. Ann N Y Acad Sci, 2001, 936: 65-88.
  • 3Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol, 2005, 27: 81-90.
  • 4Roberts HR, Stinchcombe TE, Gabriel DA. The dysfibrinoge- naemias. Br J Haematol, 2001, 114: 249-257.
  • 5Spraggon G, Everse SJ, Doolittle RF. Crystal structures of frag- ment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature, 1997, 389: 455-462.
  • 6Ishikawa S, Hirota-Kawadobora M, Tozuka M, et al. Recombi- nant fibrinogen, gamma 275 Arg→Cys, exhibits formation of di- sulfide bond with cysteine and severely impaired D: D interac- tions. J Thromb Haemost, 2004, 2: 468-475.
  • 7Borrell M, Garl M, Coll I, et al. Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinoge- naemias : Barcelona Ⅲ and IV ( gamma Arg 275→His) and Villa- joyosa ( gamma Arg 275→ Cys ). Blood Coag→l Fibrinolysis, 1995, 6: 198-206.
  • 8Mimuro J, Kawata Y, Niwa K, et al. A new type of Ser substitu- tion for gamma Arg-275 in fibrinogen Kamogawa I characterized by impaired fibrin assembly. Thromb Haemost, 1999, 81: 940-944.
  • 9Sugo T, Endo H, Matsuda M, et al. A classification of the fibrin network structures formed from the hereditary dysfibrinogens. J Thromb Haemost, 2006, 4 : 1738-1746.
  • 10Hirota-Kawadobora M, Terasawa F, Suzuki T, et al. Comparison of thrombin-catalyzed fibrin polymerization and factor Ⅶa-cata- lyzed cross-linking of fibrin among three recombinant variant fi- brinogens, gamma 275C, gamma 275H, and gamma 275A. J Thromb Haemost, 2004, 2: 1359-1367.

共引文献30

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部